TCM
MIRM icon

TCG Crossover Management’s Mirum Pharmaceuticals MIRM Stock Holding History

TCG Crossover Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$124M Hold
1,062,049
– – 2.99% 8
2026
Q1 		$98.1M Buy
1,062,049
+1,000,000
+1,612% +$94.1M 2.81% 10
2025
Q4 		$4.9M Buy
+62,049
New +$4.45M 0.16% 39

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TCG Crossover Management's MIRM Position: Q2 2026 in Review

TCG Crossover Management held its Mirum Pharmaceuticals (MIRM) position steady in Q2 2026 at 1,062,049 shares worth $124M. The position accounts for 2.99% of the portfolio, ranked #8.

TCG Crossover Management first reported a position in MIRM in Q4 2025 and has held it in 3 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • TCG Crossover Management held 1,062,049 shares of Mirum Pharmaceuticals worth $124M as of Q2 2026.
  • TCG Crossover Management left its Mirum Pharmaceuticals share count unchanged in Q2 2026.
  • Mirum Pharmaceuticals made up 2.99% of TCG Crossover Management's portfolio in Q2 2026, its #8 holding.
  • TCG Crossover Management first reported a position in Mirum Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on TCG Crossover Management's 13F filing for Q2 2026, filed 14 Aug 2026.